Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2014 Mar 3;9(3):e90385. doi: 10.1371/journal.pone.0090385

Effect of C-Terminal Residues of Aβ on Copper Binding Affinity, Structural Conversion and Aggregation

Shu-Hsiang Huang 1, Shyue-Chu Ke 2, Ta-Hsin Lin 3,4, Hsin-Bin Huang 5, Yi-Cheng Chen 1,*
Editor: Eugene A Permyakov6
PMCID: PMC3940864  PMID: 24594588

Abstract

Many properties of Aβ such as toxicity, aggregation and ROS formation are modulated by Cu2+. Previously, the coordination configuration and interaction of Cu2+ with the Aβ N-terminus has been extensively studied. However, the effect of Aβ C-terminal residues on related properties is still unclear. In the present study, several C-terminus-truncated Aβ peptides, including Aβ1-40, Aβ1-35, Aβ1-29, Aβ1-24 and Aβ1-16, were synthesized to characterize the effect of Aβ C-terminal residues on Cu2+ binding affinity, structure, aggregation ability and ROS formation. Results show that the Aβ C-terminal residues have effect on Cu2+ binding affinity, aggregation ability and inhibitory ability of ROS formation. Compared to the key residues responsible for Aβ aggregation and structure in the absence of Cu2+, it is more likely that residues 36–40, rather than residues 17–21 and 30–35, play a key role on the related properties of Aβ in the presence of Cu2+.

Introduction

Alzheimer's disease (AD) is a neurodegenerative disorder that destroys neuronal cells in the human brain [1], [2]. Numerous reports have shown that one of the pathological hallmarks in the brain of AD patients is the cerebral senile plaques [1], [2]. Senile plaques contain 90% of β-amyloid peptide (Aβ), including Aβ1-40 and Aβ1-42, which is a proteolytic product of amyloid precursor protein (APP) [3][5]. The others remained in senile plaques include apolipoproteins E, lipids from membranes of degenerated portions of neuron, and abnormally high concentration of metal ions such as Cu2+, Zn2+, or Fe2+ [6], [7].

In the amyloid cascade hypothesis, the Aβ aggregates are proposed to be the main toxic species and the cause of AD [8], [9]. Aβ adopts a β-sheet conformation in the aggregated state, and the amyloid aggregates can induce free radical formation and subsequently cause neuronal death [8], [9]. Among the Aβ aggregates, oligomer and protofibril rather than mature amyloid fibril have been demonstrated to be the most toxic species to neurons [10][12]. The aggregation and toxicity of Aβ is well correlated with its sequence and structure [13][15]. Previous studies using different Aβ fragments or truncated Aβ peptides reported that residues 17–21 and 30–35 are the most important regions for aggregation and neurotoxicity [14], [15].

The deposition of Aβ has been shown to be modulated by metal ions [6], [7], particularly Cu2+. Abnormally high concentrations of Cu2+ have been found in cerebral amyloid-deposits of AD patients [6]. It has been shown that Cu2+ is bound to Aβ [6], [16]. Either one or two Cu2+ bound to Aβ peptide has been proposed. The binding site is mainly located at the N-terminus of Aβ, particularly the three histidine residues (His6, His13 and His14), and forms a 3N1O coordination configuration [16], [17]. The reported Cu2+ binding affinities for monomeric Aβ vary widely between micromolar and nanomolar [18]. The effect of Cu2+ ion on Aβ has been shown to be twofold, the first is to accelerate the aggregation of Aβ, [19], [20], and the second is to induce the formation of reactive oxygen species (ROS) [18], [21].

The role of Aβ coordinated with Cu2+ on the free radical has still been under debate. Both pro-oxidant and antioxidant roles for Aβ associated with the ROS produced by Cu2+ have been suggested [21][23]. Although early studies suggested that Aβ peptides can spontaneously produce free radicals [14], [18], [19], [22], several studies have shown that Aβ required the presence of Cu2+ to produce ROS [18], [21], [22]. The possible mechanism of ROS formation may be through a series of electron transfer reactions when Cu2+ binds to Aβ [18], [21]. The ROS induced by Aβ/Cu2+ aggregates is reduced by addition of other antioxidants or Cu-selective chelators [17], [23][25]. As opposed to the pro-oxidant role, other studies have proposed an antioxidant activity of Aβ [26][28]. In particular, monomeric Aβ1-40 has been shown to inhibit neuronal death caused by Cu2+ induced oxidative damage [27], [28]. Furthermore, Viles group has demonstrated that Aβ does not silence the redox reaction of Cu2+ via chelation but react with the hydroxyl radicals produced by Cu2+/ascorbate and quench the harmful oxidative species [26].

The effect of Aβ sequence on structure, aggregation ability and ROS formation in the absence of Cu2+ has been extensively studied [14], [15]. In general, residues 17–21 and 30–35 are identified as the key region responsible for aggregation and neurotoxicity [14], [15]. In the presence of Cu2+, the interaction and coordination configuration of Aβ/Cu2+ complex have been characterized [16][18]. However, most of these studies have focus on the elucidation of interaction and coordination configuration of the Aβ N-terminus with Cu2+. So far, the effect of Aβ C-terminal residues on Cu2+ binding affinity, aggregation ability and ROS formation in the presence of Cu2+ has yet been studied.

In the present study, we investigated the effect of Aβ C-terminal residues on Cu2+ binding affinity, structure, aggregation ability and ROS formation. Full length Aβ1-40 and several C-terminus-truncated Aβ peptides, including Aβ1-35, Aβ1-29, Aβ1-24 and Aβ1-16 were synthesized and used to characterize these subjects. Our results indicated that, though the major Cu2+ binding site is located at N-terminus of Aβ, the C-terminal residues of Aβ, particularly residues 36–40, have a significant effect on the binding affinity of Cu2+, conformation, aggregation ability and the inhibitory ability of ROS driven by Cu2+.

Materials and Methods

Synthesis and purification of Aβ peptides

The synthesis of Aβ peptides, including Aβ1-40, Aβ1-35, Aβ1-29, Aβ1-24 and Aβ1-16, were performed in a solid-phase peptide synthesizer (PS3, Protein Technologies, Inc., AZ) using the FMOC protocol with HMP resin. After cleavage from the resin with a mixture of trifluoroacetic acid/H2O/ethanedithiol/thioanisole/phenol, the peptides were extracted with 1∶1 (v:v) ether: H2O containing 0.1% 2-mercaptothanol. The synthesized Aβ peptides were purified using a C18 reverse-phase column with a linear gradient from 0% to 78%. Peptide purity was over 95% as identified by MALDI–TOF mass spectrometer. One mg of purified Aβ peptides was dissolved in 1 ml trifluoroethanol, and centrifuged (20,000×g) to sediment the insoluble particles. This Aβ solution was then dried under N2 gas and resuspended in 1 ml phosphate buffer, pH 7.4, to provide a stock solution, and stored at −80°C until used.

Copper binding affinity assay

Tyrosine fluorescence spectroscopy was used to characterize the binding affinity of Cu to Aβ [28]. Before measurements, the stock solution containing the different C-terminal truncated Aβ peptides was diluted in Dulbecco's PBS, pH 7.0 to a final peptide concentration of 10 μM with different molar ratios of CuCl2. Spectra were collected on a microplate reader (FlexStation 3, MD). The excitation and emission wavelength was 278 and 305 nm, respectively. The intensity change at 305 nm was used to calculate the binding constant. Previously, the number of Cu ion bound to Aβ has been debated. Either one or two Cu ion has been proposed to bind to Aβ [29], and there is no two-Cu/Aβ complex structure available. Two-degenerate scheme for either one- or two-Cu binding modes was hence considered and applied to calculate the binding constant.

For the one-Cu2+ binding mode, the general equation for Cu2+ binding is as follows:

graphic file with name pone.0090385.e001.jpg

, the degree of saturation, Y, can be written as

graphic file with name pone.0090385.e002.jpg
graphic file with name pone.0090385.e003.jpg

, where Io and Ix are the fluorescence intensity in Cu-free and Cu-bound state, respectively. I is the fluorescence intensity at saturation state, [Cu2+] is the copper concentration, n is the copper binding number and Ka is the association constant.

For the two-Cu2+ binding mode, the two Cu2+ ions are bound to Aβ located at the N-terminal His-pocket. The general equation for Cu2+ binding is as follows:

graphic file with name pone.0090385.e004.jpg
graphic file with name pone.0090385.e005.jpg

The tyrosine fluorescence spectrum at any concentration is the net combination of the Cu-free and Cu-bound forms weighted by their concentrations. Two general models based on linked two-site binding are proposed.

The first model (dependent mode) is one in which the two Cu binding sites interact so that the second Cu2+ ion binds with a different binding constant than the first. The degree of saturation for the dependent mode can be described as follows [30]:

graphic file with name pone.0090385.e006.jpg

The second model (independent mode) assumes that the two binding sites, due to the different structure or accessibility, are independent with each other and should have equal binding constant (Ka1 =  Ka2) for the two Cu2+ ions [30]. The degree of saturation for the independent mode is described as follows:

graphic file with name pone.0090385.e007.jpg

The related parameter was calculated using the nonlinear curve fitting function in the Origin6.0 program (Microcal Software, Inc., Nothampton, MA). This nonlinear fitting program uses the Levenberg-Marquardt nonlinear least-squares fitting algorithm. In the initial fitting stage, the Simplex method, which was set to 100 cycle runs, was used to calculate the initial parameter for further nonlinear curve fitting. A 0.95 confidence level was set to constrain the quality of curve fitting. The final fitting parameters were obtained when the value of χ2 was less than 0.05 and the parameters and errors for the parameters reached the convergent and steady state.

Circular dichroism (CD) spectroscopy

Thirty μM of fresh peptide samples, diluted from the stock solution in phosphate buffer, pH 7.0, in the presence or absence of 30 μM Cu2+ were used for CD measurements. CD spectra were recorded, within 1 hr after samples prepared, using either an Aviv 420 spectropolarimeter or synchrotron radiation CD (04B1) in the national synchrotron radiation center, Taiwan. All measurements were performed in a quartz cell with pathlength of 0.1 cm. Spectra were collected at the wavelengths from 190 to 260 nm in 0.5 nm increments. Reported CD spectra were the average from three repeats of samples. The reported CD spectra were corrected for baseline using the solution of PBS buffer, pH 7.0 and Cu2+ ions. The secondary structure analysis was calculated using CDSSTR program in Dicroweb website [31].

The β-sheet propensity is defined as Inline graphic. So and S represent the percentage of β-sheet content in Cu-free and saturated Cu-bound state, respectively. Co and C are the concentrations of Cu2+ in Cu-free and saturated Cu-bound state, respectively.

Aggregation assay

The aggregation process of Aβ peptides in the presence or absence of Cu2+ was assessed by the turbidity assay. Thirty μM of Aβ peptides were placed in a 96-well plate and incubated in the presence or absence of 30 μM CuCl2 at 37°C. Turbidity was measured using a microplate reader (FlexStation 3, MD) at a wavelength of 450 nm.

ROS assay

ROS (H2O2) level induced by Aβ/Cu2+ was analyzed using the dichlorofluoresein diacetate (DCFH-DA) assay [17]. Dichlorofluorescein diacetate was dissolved in 100% dimethyl sulfoxide (DMSO), deacetylated with 1∶1 (v/v) 4 M NaOH for 30 min, and then neutralized (pH 7.2) to a final concentration of 200 μM as stock solution. This stock solution was kept on ice and in the dark until use. The reaction was carried out in a 96-well plate (100 μl/well) in Dulbecco's PBS, pH 7.2, containing the designed concentrations of Aβ peptides, 30 μM of CuCl2, 20 µM deacylated DCF and 5 μM horseradish peroxidase, and incubated at 37°C for 1 hr. Measurements were performed on the day of sample prepared. Fluorescence readings were recorded on the microplate reader (Flexstation3, MD). The excitation and emission wavelengths were 485 and 530 nm, respectively.

Electron paramagnetic resonance (EPR) spectroscopy

Samples containing 300 μM of Aβ peptides and Cu2+ ions in 30% glycerol phosphate buffer, pH 7.2, freshly prepared from peptide stock solution were employed for EPR spectroscopic measurements. EPR spectra were obtained at X-band using a Bruker EMX ER073 spectrometer equipped with a Bruker TE102 cavity and an advanced research system continuous-flow cryostat (4.2–300 K). During EPR experiments, the sample temperature was maintained at 10 K. The microwave frequency was measured with a Hewlett-Packard 5246L electronic counter.

Transmission Electron Microscopy (TEM)

A transmission electron microscopy (JEM-2000 EXII, JEOL, Japan) with an accelerating voltage of 100 KeV was used to analyze the morphology of Aβ peptides incubated with Cu2+. Ten microliters of sample with the different Aβ peptides and Cu2+ ions in 1∶1 molar ratio used for the aggregation assay was used. Each peptide sample was placed onto a carbon-coated 200 mesh copper grid (Pelco, Ca, USA). Excess solution was wicked dry with tissue paper, and the sample was negatively stained with 5 ml of 2% uranyl acetate for 30 seconds. After TEM analyses, these copper grids coated with Aβ samples used for TEM analyses were further treated with 50 μL 1 mM EDTA solution three times to strip off Cu2+ ions and then incubated at 37°C for 24 hrs. These copper grids coated with Aβ samples treated with EDTA were then conducted for TEM analyses to observe the morphology of Aβ peptides in absence of Cu2+.

Results

Correlation of Cu binding affinity and Aβ sequence

The aggregation and toxicity of Aβ has been demonstrated to be modulated by Cu2+ [6], [7], [17], [18], [21]. The interaction of Cu2+ with Aβ N-terminus has been extensively studied [17], [18], [32][34]. The number of Cu2+ bound to Aβ has been debated which either one or two Cu2+ has been proposed [17], [18], [29]. On the other hand, the effect of C-terminal residues on Cu2+ binding affinity and other properties has yet to be studied. In order to unveil the effect of C-terminal residues on Cu2+ binding affinity and other properties, several Aβ peptides, including Aβ1-40, Aβ1­35, Aβ1­29, Aβ1­24, Aβ1­16 and Aβ25-35, were synthesized and used to characterize the correlation with Cu2+ binding affinity, structural changes and aggregation ability.

To characterize the Cu2+ binding affinity, tyrosine fluorescence spectroscopy was used to determine the Cu2+ binding constants. Figures 1 (A–E) show the tyrosine fluorescence titration curves as a function of tyrosine fluorescence intensity vs. Cu2+ concentration for Aβ1-40, Aβ1­35, Aβ1­29, Aβ1­24, and Aβ1­16, respectively. Both one-Cu and two-Cu binding modes were applied to estimate the Cu2+ binding constants. As shown in Fig. 1, the two-Cu mode (solid line) shows to fit the titration curve better than the one-Cu mode (dot line) for all Aβ peptides, indicating that the Cu2+ binding site is more likely to locate two ions instead of one ion for all Aβ peptides. For the two-Cu mode, we further tested if the two Cu2+ ions bound to Aβ are dependent or independent of each other. As shown in Figs. 1 (A–E), for all Aβ peptides, the non-linear fitting curves were only convergent by using the dependent mode, suggesting that the binding constant of two Cu2+ ions should be different for each other.

Figure 1. Tyrosine fluorescence spectra for the determination of Cu2+ binding affinity.

Figure 1

(A) Aβ1-16, (B)Aβ1-24, (C)Aβ1-29, (D)Aβ1-35, (E)Aβ1-40. The concentration of Aβ peptides was 10 µM. The solid lines represent the best fitting curve using the independent two-Cu mode, whereas dot lines show the fitting curve simulated using one-Cu mode as depicted in the section of material and methods.

The calculated binding constants are summarized in Table 1. The Ka1 value was approximately hundredfold higher than the Ka2 value for all Aβ peptides, indicating that the first Cu binds to Aβ much stronger that the second Cu does. The Ka1 value was in the range of 0.06–0.13 μM, and the Ka2 value was in the range of 0.0007–0.0013 μM. In general, both Ka1 and Ka2 were dependent on sequence. The value of Ka1 was increased with an increase of Aβ C-terminal residues, except of Aβ1-35. The Ka1 value of Aβ1-40 was approximately twofold higher than that of Aβ1-16. In contrast, the trend of Ka2 value was opposite to that of Ka1 value which the Ka2 values of Aβ1-24 and Aβ1-16 were higher than those of Aβ1-29, Aβ1-35 and Aβ1-40. The Ka2 value of Aβ1-24 was approximately twofold higher than that of Aβ1-35. The Ka1value for Aβ peptides was in the order of Aβ1-40≥ Aβ1-29≥ Aβ1-35≈ Aβ1-24> Aβ1-16, whereas the Ka2 value for Aβ peptides was in the order of Aβ1-24≥ Aβ1-16≥ Aβ1-29≈ Aβ1-40≈ Aβ1-35.

Table 1. The estimated copper (II) binding constant using one-Cu and dependent two-Cu models for the different Aβ peptides.

One-Cu Two-Cu (dependent)
Ka Ka1 Ka2 R2 χ
Aβ1-16 0.07±0.02 0.06±0.01 0.0011±0.0001 0.98 0.0019
Aβ1-24 0.10±0.04 0.09±0.02 0.0013±0.0004 0.97 0.0038
Aβ1-29 0.12±0.03 0.11±0.02 0.0009±0.0003 0.98 0.0016
Aβ1-35 0.10±0.01 0.09±0.01 0.0007±0.0001 0.99 0.0010
Aβ1-40 0.14±0.02 0.13±0.01 0.0008±0.0002 0.98 0.0019

EPR spectra of Aβ/Cu2+ complexes

As we showed that the C-terminal residues of Aβ can affect the Cu2+ binding affinity, it is of interest to examine if the interaction of the C-terminal residues with Cu2+ alters the coordination configuration of Aβ/Cu2+. In order to characterize the coordination configuration, EPR spectroscopy was used to determine the coordination configuration of Aβ/Cu2+ for the different C-terminus-truncated Aβ peptides.

Figure 2 shows the EPR spectra for Cu2+ with Aβ1-40, Aβ1-35, Aβ1-29, Aβ1-24 and Aβ1-16. The EPR parameters of g, g|| and A are listed in Table 2. It can be seen that the hyperfine peaks of EPR spectra for the different Aβ peptides showed a similar pattern. The estimated g, g|| and A parameters for the different Aβ peptides were similar and very close to literature report in aqueous condition except of Aβ1-16 [33], [34]. The values of g, g|| and A were approximately 2.060, 2.266 and 169 for all Aβ peptides except of Aβ1-16. The value of A parameter for Aβ1-16 is slightly lower than that for the other Aβ peptides, indicating that the Cu2+ binding affinity of Aβ1-16 is relatively weak compared to the other Aβ peptides. In general, our results indicate that the coordination configuration of Cu2+ for Aβ peptides adopt mainly a 3N1O ligand-donor-atom set [17], [18], [29], [32], [33], and the main coordination configuration of Aβ/Cu2+, located at the N-terminus was not significantly altered by the association of C-terminus of Aβ.

Figure 2. EPR spectra for the characterization of coordination configuration.

Figure 2

EPR spectra for Aβ1-16 (black), Aβ1-29 (red), Aβ1-35 9greeen), and Aβ1-40 (blue) in the presence of Cu2+. The characteristic g|| and g hyperfine peaks appeared spectra represent that Cu2+ ion coordinates with Aβ peptides in a similar coordination configuration.

Table 2. The estimated EPR parameters of Aβ/copper (II) complex for the different Aβ peptides.

g g|| A
Aβ1-16 2.061 2.266 160
Aβ1-24 2.060 2.266 168
Aβ1-29 2.060 2.266 169
Aβ1-35 2.060 2.265 168
Aβ1-40 2.060 2.265 170

Secondary structure of Aβ peptides in the presence of Cu2+

Previous results show that the increase of C-terminal residues increased the Cu2+ binding affinity but did not cause any significant change of Aβ-Cu2+ coordination configuration. However, several studies have shown that the binding of Cu2+ to Aβ can induce a conformational conversion from either helix or random coil into β–sheet [19], [20]. Therefore, the effect of C-terminal residues on the secondary structure of Aβ peptides in the presence of Cu2+ was examined by using CD spectroscopy.

Figures 3 (A) and (B) show the CD spectra for the different Aβ peptides in the absence or presence of Cu2+ ions, respectively. Table 3 summarizes the estimated content of secondary structure. In general, in the absence of Cu2+, all Aβ peptides adopt a high percentage of random coil. Aβ1-16 contained the highest percentage of random coil (72%) and the lowest percentage of β-sheet (24%), whereas other Aβ peptides contained a similar secondary structure content, 30–34% of β-sheet, 61–64% of random coil and 4–5% of α-helix. In the presence of Cu2+, the secondary structure content for Aβ1-35, Aβ1-29, and Aβ1-24 peptides was similar to that obtained in the absence of Cu2+. For Aβ1-16, the β-sheet percentage was slightly increased (27%), and the random coil percentage was slightly decreased (70%). In contrast to other C-terminus-truncated Aβ peptides, the secondary structure of Aβ1-40 showed a dramatic change while adding the Cu2+ ions. The β-sheet content of Aβ1-40 increased from 34% to 47%, and the random coil percentage of Aβ1-40 decreased from 61% to 50% in the presence of Cu2+.

Figure 3. Circular dichroism spectra of Aβ peptides.

Figure 3

CD spectra for different Aβ peptides, (▿) Aβ1-16, (□) Aβ1-24, (•) Aβ1-29, (○) Aβ1-35, (▪) Aβ1-40, in the absence (A) and presence (B) of Cu2+. The concentration for both Aβ peptides and Cu2+ used in measurements was 30 µM. A normalized root mean square standard deviation (NRMSD) parameter was introduced to indicate for the quality between observed and calculated CD spectra.

Table 3. The content of secondary structure for the different Aβ peptides in the presence or absence of Cu2+ as calculated from CD spectra.

Α-helix (%) B-sheet (%) Random coil (%) NRMSD*
Aβ1-16 4 24 72 0.01
Aβ1-24 5 31 64 0.06
Aβ1-29 5 30 65 0.10
Aβ1-35 5 30 65 0.12
Aβ1-40 5 34 61 0.03
Aβ1-16/Cu2+ 3 27 70 0.11
Aβ1-24/Cu2+ 3 34 63 0.008
Aβ1-29/Cu2+ 3 35 62 0.14
Aβ1-35/Cu2+ 4 34 62 0.11
Aβ1-40/Cu2+ 3 47 50 0.02

*NRMSD (normalized root mean square standard deviation)  =  [(θobs(λ)-θcal(λ))2/(θobs(λ))2]1/2.

We further analyzed the correlation between secondary structure and Cu2+ concentration. The plot of secondary structural content (β-sheet, random coil and α-helix) vs. Cu2+ concentration for Aβ peptides is depicted in Figures 4 (A–C), respectively. In general, the contents of β-sheet and random coil for Aβ1-40, Aβ1-35, Aβ1-29, and Aβ1-24 were dependent on Cu2+ concentration, whereas the secondary structure content of Aβ1-16 was independent of Cu2+ concentration. For Aβ1-40, Aβ1-35, Aβ1-29, and Aβ1-24, the content of β-sheet structure increased with an increase of Cu2+ concentration (fig. 4 (A)), whereas the content of random coil decreased with an increase of Cu2+ concentration (fig. 4 (B)). The α-helix content showed no obvious change with the increase of Cu2+ concentration for all Aβ peptides (fig. 4 (C)). The change of β-sheet content for Aβ1-40 was more significant than those for other Aβ peptides. Furthermore, the relationship between β-sheet propensity and Aβ sequence in the presence of Cu2+ was also correlated by plotting the β-sheet propensity in the presence of Cu2+ vs. Aβ sequence. As it can be seen that has the β-sheet propensity of Aβ1-40 is significantly higher than those for other Aβ peptides. This is generally agreement with the result obtained from Ka1 binding constant which Aβ1-40 has the higher Cu-binding affinity.

Figure 4. The plot of secondary structure content vs. Cu2+ concentration.

Figure 4

The plot for different Aβ peptides, (▪) Aβ1-16, (♦) Aβ1-24, (▴) Aβ1-29, (○) Aβ1-35, (▾) Aβ1-40 and (A) β–sheet percentage, (B) random coil percentage, and (C) α-helx. (D) The plot of β–sheet propensity vs. Aβ peptides.

Aggregation ability for Aβ peptides

It has been shown that the binding of Cu2+ can modulate the aggregation mechanism of Aβ [6], [14], [33]. As demonstrated by the present study, the conformational conversion into β-strand structure was dependent on Aβ C-terminal residues in the presence of Cu2+. In order to further characterize the effect of C-terminal residues on Aβ aggregative ability, we analyzed the aggregation profiles for the different C-terminus-truncated Aβ peptides in the presence of Cu2+.

Figures 5 (A) and (B) show the aggregation profiles for Aβ1-40, Aβ1-35, Aβ1-29, Aβ1-24, and Aβ1-16 in the absence and presence of Cu2+, respectively. As shown in figure 5 (A), only Aβ1-40 was able to form aggregates in the absence of Cu2+, whereas the other Aβ peptides remained at nucleation state in the absence of Cu2+. In the presence of Cu2+, Aβ1-40, Aβ1-35 and Aβ1-29 were able to aggregate, whereas Aβ1-24 and Aβ1-16 remained at nucleation state (fig. 5 (B)), indicating that the C-terminal residues of Aβ, particularly residues 25–40, have effect on the aggregation in the presence of Cu2+. The aggregation rate for Aβ1-40 in the presence of Cu2+ was faster than the rates for Aβ1-35 and Aβ1-29. This result further suggests that the C-terminal residues, particularly 36–40, may play an important role on the aggregation mechanism of Aβ driven by Cu2+. In general, the aggregation ability is in the order of Aβ1-40> Aβ1-35≈ Aβ1-29>> Aβ1-24≈ Aβ1-16.

Figure 5. The aggregation profiles.

Figure 5

The aggregation profile determined by turbidity assay in the absence (A) and the presence (B) of Cu2+ for different Aβ peptides, (⋄) Aβ1-16, (▾) Aβ1-24, (▴) Aβ1-29, (○) Aβ1-35, and (▪) Aβ1-40.

TEM morphology of Aβ peptides

As shown in the previous sections that the C-terminal residues of Aβ have impact on Cu2+ binding affinity, secondary structure and aggregative ability. Therefore, we wondered if the C-terminal residues have any effect on the morphologies of fibrils formed by the Aβ peptides. To examine the effect of C-terminal residues on the morphologies of Aβ fibrils in the presence of Cu2+, transmission electronic microscopy was used to observe the fibril morphologies.

Figures 6 (A), (C), (E) and (G) show the morphologies for Aβ1-40, Aβ1-36, Aβ1-29 and Aβ1-16 in the presence of Cu2+ (molar ratio Aβ/Cu  = 1), respectively. It can be seen that most Aβ peptides formed a non-amyloid-like morphology in the presence of Cu2+, except of Aβ1-16 which did not form any amyloid fibrils. The same Aβ peptides/Cu2+ samples of the same spots were then treated with 1mM EDTA to strip off the Cu2+ ions and further incubated at 37°C and 24 hrs. After Cu2+ ions were depleted by EDTA, the morphology of Aβ peptides was then analyzed using TEM. Figures 6 (B), (D), (F) and (H) show the TEM images for morphologies of Aβ1-40, Aβ1-36, Aβ1-29 and Aβ1-16, respectively. The morphologies for Aβ1-40, Aβ1-35 and Aβ1-29 aggregates in the presence of Cu2+ are obviously very different from the morphologies of these peptides with Cu2+ stripped off by EDTA. In figure 6 (B), the fibril of Aβ1-36 was a typical amyloidogenic and network-like morphology after Cu2+ was stripped off by EDTA. On the other hand, the fibrils of both Aβ1-29 (fig. 6(E)) and Aβ1-40 (fig. 6(A)) with Cu2+ stripped off by EDTA were shorter and non-network-like morphology. For both Aβ1-16 and Aβ1-24, they did not form any fibril in the presence or absence of Cu2+.

Figure 6. The TEM images of Aβ fibril morphologies.

Figure 6

Images A, C, E and G represent the fibril morphologies for Aβ1-40, Aβ1-35, Aβ1-29 and Aβ1-16 with Cu2+ stripped off by EDTA, respectively. Images B, D, F and H represent the morphologies for Aβ1-40, Aβ1-35, Aβ1-29 and Aβ1-16 in the presence of Cu2+, respectively.

Correlation of H2O2 formation and Aβ sequence in the presence of Cu2+

The role of Aβ/Cu2+ on the formation of ROS is controversial. Both antioxidant and pro-oxidant roles for Aβ on the ROS formation in the presence of Cu2+ have been proposed [20][23]. In order to elucidate the effect of Aβ C-terminal residues on either antioxidant or pro-oxidant role, a DCF assay which usually detects the formation of H2O2 was used to measure the level of ROS for the different Aβ peptides in the presence of Cu2+.

Figure 7 shows the plot of DCF fluorescence intensity vs. Aβ concentration. For most C-terminus-truncated Aβ peptides, the DCF fluorescence intensity was decreased with an increase of Aβ concentration, indicating that the formation of H2O2 was inhibited by most Aβ peptides, except of Aβ25-35. For Aβ25-35, which lacks the Cu2+ binding site, did not show to inhibit the formation of H2O2. The H2O2 level was equal to that of Cu2+ only. For the comparison of inhibitory ability for these Aβ peptides, only full-length Aβ1-40 was able to completely inhibit the formation of H2O2 at the molar ratio of Aβ/Cu2+  = 1, whereas for other peptides such as Aβ1-35, Aβ1-29, Aβ1-24 and Aβ1-16, the formation of H2O2 was not completely inhibited at the molar ratio of Aβ/Cu2+  = 1. A higher peptide concentration was needed to completely reduce the H2O2 level to zero for C-terminus-truncated Aβ peptides.

Figure 7. The plot of DCF fluorescence intensity vs. Aβ concentration.

Figure 7

The plot for different Aβ peptides, (▴) 30 µM Cu2+ alone, (♦) Aβ1-16, (▵) Aβ1-24, (•) Aβ1-29, (○) Aβ1-35, (◊) Aβ1-40, and (▿) Aβ25-35 in the presence of 30 µM Cu2+. Instead of generating H2O2, most Aβ peptides, except of Aβ25-35, inhibit the generation of H2O2. All measurements were measured after the fresh prepared samples were incubated at 37°C for 1 hr.

Since the Cu2+ binding affinity was showed to be proportional with the length of C-terminal residues, taken together, our results further suggest that the Cu2+ binding affinity may be the key factor for the inhibition of H2O2 formation driven by Cu2+. In general, the inhibitory ability of ROS for these Aβ peptides was proportional with the binding affinity of Cu2+ and in the order of Aβ1-40> Aβ1-29> Aβ1-35≈ Aβ1-24≈ Aβ1-16>> Aβ25-35.

Discussion

Amyloid cascade hypothesis proposes that the aggregated Aβ species are toxic to neurons and the main cause of Alzheimer's disease [6]. The various forms of Aβ, including monomer, oligomer and fibril, have been shown to coordinate with redox active transition metals, such as Cu2+ and Fe3+, which induce the formation of ROS [17], [18], [20], [21]. Although the interaction and coordination configuration of Aβ/Cu2+ complexes has been extensively studied [16][18], [29], [32][34], the effect of Aβ sequence, particularly C-terminal residues, on Cu2+ binding affinity, structural property, aggregative ability and ROS formation still remains to be elucidated.

In the present study, results demonstrate that the C-terminal residues of Aβ have significant effect on Cu2+ binding affinity, structure, aggregation ability and inhibitory ability of ROS. For Cu2+ binding affinity, the C-terminal residues of Aβ, particularly residues 25–29 and 36–40, have a strong effect on Cu2+ binding affinity as evidenced by the fact that the Cu2+ binding constants for Aβ1-40 and Aβ1-29 are higher than those for other C-terminus-truncated Aβ peptides. Even though the Cu2+ binding affinity is dependent on C-terminal residues of Aβ, the coordination configurations of Aβ/Cu2+ are not significantly altered by the interaction C-terminal residues with Cu2+ as the hyperfine patterns and parameters obtained from EPR spectroscopy are similar for these different Aβ peptides. The coordination configuration of Aβ/Cu2+ still adopt the a 3N1O mode, and His6, His13 and His14 residues are the main amino acid residues to interact with Cu2+ even for C-terminus-truncated peptides [32], [33]. For the Cu-binding mode, our present study shows that the Cu2+ binding site for all Aβ peptides is able to locate two Cu2+ ions. These two Cu2+ ions bound to Aβ is dependent on the C-terminal residues. The binding constant for the first Cu2+ ion is higher than that for the second Cu2+ ion. This is consistent with a previous study [29]. The fold difference between the first Cu2+-binding constant and the second Cu2+-binding constant is also dependent on Aβ C-terminal residues, ranged from 160 folds for Aβ1-40 to 10 folds for Aβ1-16, respectively. However, the binding constants obtained in this study are somehow lower than the previous report [29]. The possible reason may be two folds; the first reason may be due that the concentration of Aβ peptides used is lower than the previous study, and the second reason may be caused by the different method applied.

It is interesting to note that the trend of Ka1 and Ka2 is generally opposite to each other. The Ka1 values are higher for Aβ peptides with residues 25–29 and 36–40, whereas the Ka2 values for Aβ peptides with residues 25–29 and 36–40 are generally lower compared to other C-terminus-truncated peptides. This indicates that the residues 25–29 and 36–40 possibly increase the binding affinity of the first Cu2+ ion and decrease the binding of the second Cu2+ ion. This result may provide an explanation for the previous observation that the second Cu site is only observed in the shorter truncated Aβ peptides such as Aβ1-16 [35], since the C-terminal residues, particularly residues 36–40, may impede the binding of the second Cu2+. However, the second Cu2+ binding constant is rather small compared to the binding constant of the first Cu2+, thereby the role of second Cu2+ ion also has little effect on the function of Aβ such as coordination geometry. The effect of Cu-binding on Aβ function is mainly attributed from the binding of the first Cu2+ ion.

Besides the effect of C-terminal residues on Cu2+ binding affinity, the C-terminal residues also show to have impact on the structural property of Aβ in the presence of Cu2+. From the result of secondary structural analysis, Aβ1-40 has the highest β-sheet propensity, indicating that residues 36–40 may play a key role on structural conversion of Aβ from random coil into β-sheet driven by Cu2+. Previously, residues 17–21 and 30–35 have been shown to be the key regions on the conformation stability for Aβ in the absence of Cu2+ [14], [15]. Our present results indicate that, in the presence of Cu2+, residues 36–40 may be more important than residues 17–21 and 30–35 for the conformational conversion of Aβ driven by Cu2+. Recently, a solid-state NMR study showed that the hydrophobic core regions of residues 18–25 and 30–36 of fibril Aβ/Cu2+ complex have little structural change [34]. Our present result is consistent with their study.

A similar effect of C-terminal residues on Aβ aggregation was obtained in the presence of Cu2+, since the aggregation ability of Aβ is highly associated with the ability of structural conversion into β-sheet [14], [15]. Previous studies showed that, in the absence of Cu2+, residues 17–21 and 30–35 are the most important regions for aggregation and neurotoxicity of Aβ [14], [15]. The present results show that the structural feature responsible for the aggregation in the presence of Cu2+ is very different from that in the absence of Cu2+. In the presence of Cu2+, the residues 36–40, instead of residues 17–21 and 30–35, are the key amino acid residues responsible for the aggregation, as Aβ1-40 has the fastest aggregation rate.

The role of Aβ on the ROS production in the presence of Cu is still under debate. Both inhibition and production of ROS by Aβ/Cu complex have been proposed [21], [22], [27], [28]. However, our results show that Aβ inhibits the ROS production in the presence of Cu. Recently, Fang and his colleagues have reported that H2O2 production is highly dependent on the state of Aβ, which monomeric Aβ tends to inhibit H2O2 production in the presence of Cu, whereas Aβ oligomer and fibril in the presence of Cu can induce H2O2 production [27]. According to their finding, our result may indicate that Aβ used in the present study may exist at monomeric state.

For the inhibition of ROS production, similar sequence-effect was also observed for the inhibitory ability of ROS formation. Results show that the inhibitory ability is also well correlated with the C-terminal residues of Aβ. Aβ1-40 with the C-terminal residues 36–40 is the only peptide which can completely inhibit the H2O2 formation, whereas the other C-terminus-truncated peptides, lacking the residues 36–40, can only inhibit the level of H2O2 to a less degree. Furthermore, the inhibitory ability is also dependent on Cu2+ binding affinity, as the binding affinity is correlated with the length of C-terminal residues. Therefore, the stronger binding constant, the higher inhibitory ability of ROS formation is.

Previous studies showed that Aβ peptides form non-amyloidogenic aggregates in the presence of Cu2+ and amyloidogenic fibril in the absence of Cu2+ [36][38]. Our present study also examined the morphologies for these Aβ peptides in the presence of Cu2+. Results show a similar observation which all Aβ peptides with Cu2+ form non-amyloidogenic aggregates. After Cu2+ ions stripped off by EDTA, only Aβ1-40, Aβ1-35 and Aβ1-29 can form a typical amyloidogenic fibril, but both Aβ1-24 and Aβ1-16 do not form any fibril. It is of interest to note that the morphologies of amyloidogenic fibril formed by Aβ1-40 and Aβ1-29 and are slightly different from the morphology of Aβ1-35 fibril. Both Aβ1-40 and Aβ1-29 form a short, rod and non-network-like fibril, whereas morphology of Aβ1-36 fibril is a typical thin and rod- and network-like fibril. The cause of the different morphologies between these peptides is unclear, but it is correlated with the sequence of Aβ and Cu2+ binding affinity, since the Cu2+ binding affinity of Aβ1-35 is weaker than those of Aβ1-40 and Aβ1-29.

In conclusion, our present results demonstrate i that the C-terminal residues of Aβ have a significant effect on Cu2+ binding affinity, structure, aggregation ability and inhibitory ability of ROS formation. Among the C-terminal residues, residues 36–40 play the most important key role on these properties. The involvement of C-terminal residues 36–40, instead of residues 17–21 and 30–35, on Cu2+ binding affinity, β-sheet conversion, aggregation ability and inhibitory ability may provide a possible explanation for the different behavior of Aβ in the presence of Cu2+.

Acknowledgments

We would also like to thank to National Synchrotron Radiation Research Center for providing the SRCD spectroscopy (04B1).

Funding Statement

This work was supported by grants from National Science Council of Taiwan, ROC (NSC101-2627-M-715-001 and NSC102-2627-M-715-002 to YCC) and MacKay Medical College, Taiwan (B1011B05 to YCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487–498. [DOI] [PubMed] [Google Scholar]
  • 2. Skovronsky DM, Doms W, Lee VM (1998) Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141: 1031–1039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Tanzi RE, Bird ED, Latt SA, Neve RL (1987) The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science 238: 666–669. [DOI] [PubMed] [Google Scholar]
  • 4. Kang J, Lemaire GH, Unterbeck A, Salbaum JM, Masters CL, et al. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733–736. [DOI] [PubMed] [Google Scholar]
  • 5. Haass C, Huang AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268: 3021–3024. [PubMed] [Google Scholar]
  • 6. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158: 47–52. [DOI] [PubMed] [Google Scholar]
  • 7. Smith MA, Harris PL, Sayre LM, Perry G (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 94: 9866–9868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB (1996) On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 93: 1125–1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Barrow CJ, Yasuda A, Kenny PT, Zagorski MG (1992) Solution conformations and aggregation properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225: 1075–1093. [DOI] [PubMed] [Google Scholar]
  • 10. Garzon-Rodriguez W, Sepulveda-Becerra M, Milton S, Glabe CG (1997) Soluble amyloid Abeta-(1–40) exists as a stable dimer at low concentrations J. Bio. Chem. 272: 21037–21044. [DOI] [PubMed] [Google Scholar]
  • 11. Dahlgren KN, Manelli AM, Stine WB, Baker Jr LK, Krafft GA, et al. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277: 32046–32053. [DOI] [PubMed] [Google Scholar]
  • 12. Selkoe DJ, Yamazaki T, Citron M, Podlisny MB, Koo EH, et al. (1996) The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann. N. Y. Acad. Sci. 777: 57–64. [DOI] [PubMed] [Google Scholar]
  • 13. Lee EK, Hwang JH, Shin DY, Kim DI, Yoo YJ (2005) Production of recombinant amyloid-beta peptide 42 as an ubiquitin extension. Protein Expr. Purif. 40: 183–189. [DOI] [PubMed] [Google Scholar]
  • 14. Liao MQ, Tzeng YJ, Chang LY, Huang HB, Lin TH, et al. (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett. 581: 1161–1165. [DOI] [PubMed] [Google Scholar]
  • 15. Liu R, McAllister C, Lyubchenko Y, Sierks MR (2004) Residues 17–20 and 30–35 of beta-amyloid play critical roles in aggregation. J. Neurosci. Res. 75: 162–171. [DOI] [PubMed] [Google Scholar]
  • 16. Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, et al. (2001) Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 276: 20466–20473. [DOI] [PubMed] [Google Scholar]
  • 17. Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, et al. (2002) Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2. J. Biol. Chem. 277: 40302–40308. [DOI] [PubMed] [Google Scholar]
  • 18. Faller P (2009) Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer. Chembiochem. 10: 2837–2845. [DOI] [PubMed] [Google Scholar]
  • 19. Morgan DM, Dong J, Jacob JJ, Lu K, Apkarian RP, et al. (2002) Metal switch for amyloid formation: insight into the structure of the nucleus. J. Am. Chem. Soc. 124: 12644–12645. [DOI] [PubMed] [Google Scholar]
  • 20. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, et al. (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273: 12817–12826. [DOI] [PubMed] [Google Scholar]
  • 21. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, et al. (1999) The Abeta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609–7616. [DOI] [PubMed] [Google Scholar]
  • 22. Smith DG, Cappai R, Barnham KJ (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 1768: 1976–1990. [DOI] [PubMed] [Google Scholar]
  • 23. Zou K, Gong JS, Yanagisawa K, Michikawa M (2002) A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22: 4833–4841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Bush AI (2002) Metal complexing agents as therapies for Alzheimer's disease. Neurobiol Aging. 23: 1031–1038. [DOI] [PubMed] [Google Scholar]
  • 25. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, et al. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30: 665–676. [DOI] [PubMed] [Google Scholar]
  • 26. Nadal RC, Rigby SE, Viles JH (2008) Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals. Biochemistry. 47: 11653–11664. [DOI] [PubMed] [Google Scholar]
  • 27. Fang CL, Wu WH, Liu Q, Sun X, Ma Y, et al. (2010) Dual functions of β-amyloid oligomer and fibril in Cu(II)-induced H2O2 production. Regul. Pept. 163: 1–6. [DOI] [PubMed] [Google Scholar]
  • 28. Rózga M, Kłoniecki M, Dadlez M, Bal W (2010) A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1–40 peptide. Chem. Res. Toxicol. 23: 336–340. [DOI] [PubMed] [Google Scholar]
  • 29. Alies B, Renaglia E, Rozga M, Bal W, Faller P, et al. (2013) Cu(II) affinity for the Alzheimer's peptide: Tyrosine fluorescence studies revisited. Anal. Chem. 85: 1501–1508. [DOI] [PubMed] [Google Scholar]
  • 30. Chen Y, Wallace BA (1996) Binding of Alkaline Cations to the Double-Helical Form of Gramicidin Biophys. J. 71: 163–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Whitmore L, Wallace BA (2004) DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data, Nucleic Acids Res. 32: 668–673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Karr JW, Kaupp LJ, Szalai VA (2004) Amyloid-beta binds Cu2+ in a mononuclear metal ion binding site. J. Am. Chem. Soc. 126: 13534–13538. [DOI] [PubMed] [Google Scholar]
  • 33. Shearer J, Szalai VA (2008) The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide. J. Am. Chem. Soc. 130: 17826–17835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Parthasarathy S, Long F, Miller Y, Xiao Y, McElheny D, et al. (2011) Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy. J. Am. Chem. Soc. 133: 3390–3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Sarell CJ, Syme CD, Rigby SE, Viles JH (2009) Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form. Biochemistry 48: 4388–4402. [DOI] [PubMed] [Google Scholar]
  • 36. Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, et al. (2011) Aluminum, copper, iron and zinc differentially alter amyloid-Aβ1–42 aggregation and toxicity. Inter. J. Biochem. Cell Biol. 43: 877–885. [DOI] [PubMed] [Google Scholar]
  • 37. Wang CC, Huang HB, Tsay HJ, Shiao MS, Wu WJ, et al. (2012) Characterization of Aβ aggregation mechanism probed by congo red J. Biomol. Struct. Dyn. 30: 160–169. [DOI] [PubMed] [Google Scholar]
  • 38. Chen YR, Huang HB, Lo CJ, Wang CC, Ho LK, et al. (2013) Effect of Alanine Replacement of L17 and F19 on the Aggregation and Neurotoxicity of Arctic-Type Aβ40. PLoS One 8: e61874. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES